The Wall Street Journal.
Feb 4, 2010 3:47 AM
India's Aurobindo Pharma said it has received approval from the U.S. Food and Drug Administration to manufacture and sell anti-allergic cetirizine hydrochloride solution.
Comments (0)
Share:
Comments (0)